×

Event Listing

Update on subject-matter eligibility at the EPO and USPTO for life sciences

15Apr

Subject-matter eligibility for life sciences inventions is an ongoing concern among applicants seeking patent protection at the USPTO. Claims that are granted in line with the USPTO guidelines for subject-matter eligibility can still fall for this same ground at the Federal Circuit. Happily, subject-matter eligibility is less controversial at the EPO. However, problems can arise when applicants try to file an EPO drafted application at the USPTO, and vice versa. In this webinar, we will look at recent updates in the case law, current USPTO guidance on Section 101, and strategies for balancing the (sometimes conflicting) requirements of the EPO and USPTO.

Audience

Fellows, Students

Speakers

K. Victoria Barker, Finnegan

K. Victoria Barker, Finnegan

Victoria is an associate in Finnegan’s London office, with experience in all areas of patent portfolio management from drafting and filing applications to prosecution strategy and beyond to EPO opposition and appeal procedures. Victoria’s experience spans a broad range of chemical technologies and key jurisdictions including China, Japan, and Korea.

Amanda K. Murphy, Finnegan LLP

Amanda K. Murphy, Finnegan LLP

Amanda Murphy, Ph.D., brings over 19 years of experience to her life sciences intellectual property practice. As a U.S. patent attorney practicing in London, Amanda focuses on developing patent filing and prosecution strategies tailored to clients’ worldwide business goals. Her practice includes patent application preparation and prosecution, pre-litigation portfolio and due diligence analyses, and contentious PTAB proceedings.

Share this page

Shopping Bag (0)

No products in the cart.

Log In